🎙 Starting a Clinical Research Site After COVID-19 Ep 267

MedEvidence! Truth Behind the Data

Send us a text

Dr. Michael Koren sits down with Alexandria Clark and Anna Fehr of One of a Kind (1-OAK) Clinical Research to discuss their bold decision to launch a clinical research company in 2021, shortly after the disruptions caused by the COVID-19 pandemic. Dr. Koren reflects on how the pandemic reshaped the clinical research landscape, forcing the closure of many smaller sites which couldn't continue seeing patients in-person. Alexandria and Anna saw an opportunity in the vacuum to build a business specializing in high-need areas like asthma, immunology, and gastroenterology. The conversation also explores the unique hurdles of establishing a new clinical research site and the importance of adaptability, planning, community, and instruction for both patients and physicians.
Koren's Key Takeaways:

• The COVID-19 pandemic changed the clinical research landscape
• Starting a new clinical research site can be a challenge and must be done with care and tact
• Clinical research sites act as a resource for the community where they are located

Be a part of advancing science by participating in clinical research.
Have a question for Dr. Koren? Email him at [email protected]
Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn
Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com
Music: Storyblocks - Corporate Inspired
Thank you for listening!

Chapters

1. Patient Engagement in Clinical Research (00:00:00)

2. Empowering Patients Through Clinical Research (00:14:23)